lobbying_activities: 3187421
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3187421 | 5495c707-fd65-4c53-a7c6-c7b4abc9cffd | Q2 | GABBERT CONSULTING CO LLC | 401105309 | CHIPPS, CAFFREY AND DUBILIER, P. S. C. | 2024 | second_quarter | MED | FDA issues final rule applying medical device rules to laboratory developed tests | HOUSE OF REPRESENTATIVES | 9000 | 0 | 0 | 2024-07-09T15:18:47-04:00 |